Pipeline
| Pipeline | Indication | Discovery | Lead Optimization |
Pre-clinical | Phase1 | Phase2 | Phase3 | NDA | ||||||
| FM101 | Non-alcoholic steatohepatitis | |||||||||||||
| Glaucoma | ||||||||||||||
| Diabetic nephropathy | ||||||||||||||
| Primary biliary cholangitis | ||||||||||||||
| FM203 | Viral disease (CHIKV, COVID, ZIKA) | |||||||||||||
| FM301 | Metastatic and resistant pancreatic cancer | |||||||||||||
| FM401 | Solid tumor | |||||||||||||
| FM503 | Autoimmune disease | |||||||||||||
| Hematologic cancer | FM701 | Non small cell lung carcinoma | ||||||||||||
| Pipeline | Indication | Graph |
| FM101 | Non-alcoholic steatohepatitis | Phase2 |
| Glaucoma | Phase2 |
|
| Diabetic nephropathy | Phase1 |
|
| Primary biliary cholangitis | Phase1 |
|
| FM203 | Viral disease (CHIKV, COVID, ZIKA) | Pre-Clinical |
| FM301 | Metastatic and resistant pancreatic cancer | Pre-Clinical |
| FM401 | Solid tumor | Pre-Clinical |
| FM503 | Autoimmune disease | Pre-Clinical |
| Hematologic cancer | Pre-Clinical |
|
| FM701 | Non small cell lung carcinoma | Pre-Clinical |
| Pipeline | Indication | Graph |
| FM101 | Non-alcoholic steatohepatitis | Phase2 |
| Glaucoma | Phase2 |
|
| Diabetic nephropathy | Phase1 |
|
| Primary biliary cholangitis | Phase1 |
|
| FM203 | Viral disease (CHIKV, COVID, ZIKA) | Pre-Clinical |
| FM301 | Metastatic and resistant pancreatic cancer | Pre-Clinical |
| FM401 | Solid tumor | Pre-Clinical |
| FM503 | Autoimmune disease | Pre-Clinical |
| Hematologic cancer | Pre-Clinical |
|
| FM701 | Non small cell lung carcinoma | Pre-Clinical |